Directly, oncolytic viruses can infect tumor cells by recognizing specific biomarkers like CD64 and laminin that are upregulated on tumor cells and indirectly inducing an immune response via cytolytic cells to attack tumor cells [336]. This evidence concerns the gene FCGR1A and neoplasm.